IP Library Granted Patent US 12,721,692
Granted Patent B2
US 12,721,692 · App. 18/787,248 · Granted Sep 1, 2026

Packaging facilitating sterile connections

Inventors: Ryan Callahan (Long Beach, CA); Leah Paige Gaffney (Orange, CA); Siddarth Shevgoor (Mission Viejo, CA)
Assignee: CAREFUSION 303, INC.
A61B50/39A61B2050/3009
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,721,692
App. No.
18/787,248
Granted
Sep 1, 2026
Kind
B2
Abstract

Packaging may be designed to allow for the forced connection of separate parts without breaching the sterile barrier of the packaging. A component holder housed within sterile packaging may hold device parts such that the device parts can shipped and stored separated and can be pushed together to create a sterile connection between the parts while the parts are housed within the packaging.

Claims (36)

1 . Packaging to facilitate a sterile connection, the packaging comprising:

an outer pouch;

a lid configured to seal the outer pouch and create a sterile interior; and

a component holder housed within the outer pouch, wherein the component holder comprises:

a board that extends longitudinally;

a first set of arms extending from the board that holds a first device part;

a second set of arms extending from the board that holds an unconnected second device part with a gap disposed between the first device part and the second device part; and

a buckling point configured to yield in a predetermined location to linearly move the first set of arms and the second set of arms closer together when forces greater than a predetermined force act upon the component holder,

wherein the component holder is configured to permit linear movement to eliminate the gap and connect the first device part to the second device part while the outer pouch remains sealed by the lid.

2 . The packaging of claim 1 , wherein the component holder is configured to maintain an orientation of the first device part and the second device part.

3 . The packaging of claim 1 , wherein the buckling point comprises a thinned section of the board of the component holder located between the first set of arms and the second set of arms.

4 . The packaging of claim 1 , wherein the first set of arms and the second set of arms removably hold the first device part and the second device part.

5 . The packaging of claim 4 , wherein the first set of arms and the second set of arms each comprise a set of two rounded arms that extend from the board.

6 . The packaging of claim 1 , wherein the lid comprises a planar piece of flexible material.

7 . The packaging of claim 1 , wherein the lid is comprised of a flexible material such that the lid is peelable from the outer pouch.

8 . The packaging of claim 1 , wherein the board is affixed to the lid.

9 . The packaging of claim 1 , wherein the outer pouch is comprised of a transparent or semi-transparent material.

10 . The package of claim 1 , wherein the transparent or semi-transparent material is capable of being deformed.

11 . Packaging to facilitate a sterile connection, the packaging comprising:

an outer pouch;

a lid configured to seal the outer pouch and create a sterile interior; and

a component holder housed within the outer pouch, wherein the component holder comprises:

a board that extends longitudinally;

a first set of arms extending from the board that holds a first device part;

a second set of arms extending from the board that holds an unconnected second device part with a gap disposed between the first device part and the second device part; and

a sliding portion configured to slide a first section of the board relative to a second section of the board, bringing the first set of arms and the second set of arms linearly closer together when forces greater than a predetermined force act upon the component holder to eliminate the gap and connect the first device part to the second device part while the outer pouch remains sealed by the lid.

12 . The packaging of claim 11 , wherein the sliding portion comprises the first section of the board and the second section of the board at least partially overlapping, and wherein the sliding portion is located between the first set of arms and the second set of arms.

13 . A method of creating a sterile connection between two or more parts using the packaging of claim 1 , the method comprising:

gripping the sealed outer pouch containing the first device part and the second device part held in stationary positions within the sealed outer pouch by the component holder;

pushing the first device part and the second device part linearly towards one another within the sealed outer pouch;

deforming the component holder at the buckling point; and

creating the connection between the first device part and the second device part to create a connected part.

14 . The method of claim 13 , further comprising peeling the lid off of the sealed outer pouch to retrieve the component holder.

15 . The method of claim 14 , further comprising removing the connected part from the component holder.

16 . The method of claim 13 , wherein the deforming the component holder comprises buckling the longitudinal board of the component holder at the buckling point.

17 . The method of claim 13 , wherein the deforming the component holder comprises sliding a first piece of the longitudinal board of the component holder over a second piece of the longitudinal board of the component holder at a designed location.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2024
From: CALLAHAN, RYAN; GAFFNEY, LEAH PAIGE; SHEVGOOR, SIDDARTH K.
To: CAREFUSION 303, INC.
Reel/Frame 069080/0662 →
Continuity (1)
Related Publication 20260026909A1 · Jan 29, 2026
References Cited (166)
US 4106621A · Sorenson · 1978 [cited by examiner]
US 5133454A · Hammer · 1992 [cited by examiner]
US 5407070A · Bascos · 1995 [cited by examiner]
US 5713856A · Eggers et al. · 1998 [cited by applicant]
US 6874522B2 · Anderson et al. · 2005 [cited by applicant]
US 7004934B2 · Vaillancourt · 2006 [cited by applicant]
US 7040598B2 · Raybuck · 2006 [cited by applicant]
US 7153296B2 · Mitchell · 2006 [cited by applicant]
US 7350764B2 · Raybuck · 2008 [cited by applicant]
US 7396051B2 · Baldwin et al. · 2008 [cited by applicant]
US 7763013B2 · Baldwin et al. · 2010 [cited by applicant]
US 7766394B2 · Sage et al. · 2010 [cited by applicant]
US 7794675B2 · Lynn · 2010 [cited by applicant]
US 7803139B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7803140B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7815614B2 · Fangrow, Jr. · 2010 [cited by applicant]
US 7918243B2 · Diodati et al. · 2011 [cited by applicant]
US 7998134B2 · Fangrow et al. · 2011 [cited by applicant]
US 8113348B2 · Foster · 2012 [cited by examiner]
US 8123738B2 · Vaillancourt · 2012 [cited by applicant]
US 8142418B2 · Mcmichael et al. · 2012 [cited by applicant]
US 8211069B2 · Fangrow, Jr. · 2012 [cited by applicant]
US 8261910B2 · Guenter · 2012 [cited by examiner]
US 8262628B2 · Fangrow, Jr. · 2012 [cited by applicant]
US 8361408B2 · Lynn · 2013 [cited by applicant]
US 8480968B2 · Lynn · 2013 [cited by applicant]
US 8777908B2 · Fangrow, Jr. · 2014 [cited by applicant]
US 8777909B2 · Fangrow, Jr. · 2014 [cited by applicant]
US 8795256B1 · Smith · 2014 [cited by applicant]
US 8888758B2 · Mansour · 2014 [cited by applicant]
US 8899267B2 · Diodati et al. · 2014 [cited by applicant]
US 8910919B2 · Bonnal et al. · 2014 [cited by applicant]
US 8974425B2 · Tachizaki et al. · 2015 [cited by applicant]
US 8974437B2 · Williams et al. · 2015 [cited by applicant]
US 9114242B2 · Fangrow et al. · 2015 [cited by applicant]
US 9126028B2 · Fangrow et al. · 2015 [cited by applicant]
US 9126029B2 · Fangrow et al. · 2015 [cited by applicant]
US 9192753B2 · Lopez et al. · 2015 [cited by applicant]
US 9234616B2 · Carrez et al. · 2016 [cited by applicant]
US 9358379B2 · Fangrow, Jr. · 2016 [cited by applicant]
US 9433769B2 · Bayly · 2016 [cited by applicant]
US 9468749B2 · Mansour et al. · 2016 [cited by applicant]
US 9492649B2 · Carrez et al. · 2016 [cited by applicant]
US 9636492B2 · Fangrow, Jr. · 2017 [cited by applicant]
US 9724504B2 · Fangrow, Jr. et al. · 2017 [cited by applicant]
US 9724505B2 · Williams et al. · 2017 [cited by applicant]
US 9861805B2 · Dennis et al. · 2018 [cited by applicant]
US 9933094B2 · Fangrow · 2018 [cited by applicant]
US 9974939B2 · Fangrow, Jr. · 2018 [cited by applicant]
US 9974940B2 · Fangrow, Jr. · 2018 [cited by applicant]
US 10029086B2 · Nowak et al. · 2018 [cited by applicant]
US 10156306B2 · Fangrow · 2018 [cited by applicant]
US 10173045B2 · Mansour · 2019 [cited by applicant]
US 10179203B1 · Huslage et al. · 2019 [cited by applicant]
US 10315025B2 · Phillips et al. · 2019 [cited by applicant]
US 10398887B2 · Fangrow, Jr. et al. · 2019 [cited by applicant]
US 10441507B2 · Sanders · 2019 [cited by applicant]
US 10518078B2 · Stjernberg Bejhed et al. · 2019 [cited by applicant]
US 10569073B2 · Hallisey et al. · 2020 [cited by applicant]
US 10625068B2 · Leuthardt et al. · 2020 [cited by applicant]
US 10655768B2 · Jones et al. · 2020 [cited by applicant]
US 10697570B2 · Fangrow · 2020 [cited by applicant]
US 10744315B2 · Sanders · 2020 [cited by applicant]
US 10842982B2 · Fangrow, Jr. · 2020 [cited by applicant]
US 10857346B2 · Dennis et al. · 2020 [cited by applicant]
US 10864362B2 · Jones et al. · 2020 [cited by applicant]
US 10881847B2 · Lynn · 2021 [cited by applicant]
US 11168818B2 · Fangrow · 2021 [cited by applicant]
US 11207514B2 · Kakinoki · 2021 [cited by applicant]
US 11235135B2 · Tsai · 2022 [cited by applicant]
US 11273297B2 · Kakinoki · 2022 [cited by applicant]
US 11484471B2 · Sanders · 2022 [cited by applicant]
US 11491084B2 · Ueda et al. · 2022 [cited by applicant]
US 20040215158A1 · Anderson · 2004 [cited by applicant]
US 20050033237A1 · Fentress · 2005 [cited by examiner]
US 20050090805A1 · Shaw et al. · 2005 [cited by applicant]
US 20060042977A1 · Sandel · 2006 [cited by examiner]
US 20060129109A1 · Shaw et al. · 2006 [cited by applicant]
US 20070088292A1 · Fangrow, Jr. · 2007 [cited by applicant]
US 20070088293A1 · Fangrow, Jr. · 2007 [cited by applicant]
US 20070088294A1 · Fangrow, Jr. · 2007 [cited by applicant]
US 20070225635A1 · Lynn · 2007 [cited by applicant]
US 20080039803A1 · Lynn · 2008 [cited by applicant]
US 20090082752A1 · Pipelka · 2009 [cited by applicant]
US 20110106046A1 · Hiranuma · 2011 [cited by applicant]
US 20140249487A1 · Lynn · 2014 [cited by applicant]
US 20140330254A1 · Rosenberger et al. · 2014 [cited by applicant]
US 20160000363A1 · Jones et al. · 2016 [cited by applicant]
US 20170088325A1 · Webster et al. · 2017 [cited by applicant]
US 20180200147A1 · Sanders · 2018 [cited by applicant]
US 20190184152A1 · Kakinoki · 2019 [cited by applicant]
US 20190282797A1 · Tsai · 2019 [cited by applicant]
US 20200113784A1 · Lopez et al. · 2020 [cited by applicant]
US 20200179672A1 · Kakinoki · 2020 [cited by applicant]
US 20200215319A1 · Fangrow, Jr. et al. · 2020 [cited by applicant]
US 20200284385A1 · Fangrow · 2020 [cited by applicant]
US 20200323734A1 · Ueda et al. · 2020 [cited by applicant]
US 20200338331A1 · Sanders · 2020 [cited by applicant]
US 20210069484A1 · Tsai · 2021 [cited by applicant]
US 20210077803A1 · Lynn · 2021 [cited by applicant]
US 20210252267A1 · Fangrow, Jr. · 2021 [cited by applicant]
US 20210388926A1 · Martin et al. · 2021 [cited by applicant]
US 20210393938A1 · Lynn et al. · 2021 [cited by applicant]
US 20220260189A1 · Deuse · 2022 [cited by applicant]
US 20220282814A1 · Fangrow · 2022 [cited by applicant]
US 20240358875A1 · Malik · 2024 [cited by examiner]
CA 2318624A1 · 1999 [cited by applicant]
EP 1678070A2 · 2006 [cited by applicant]
EP 1517723B1 · 2007 [cited by applicant]
EP 1622675B1 · 2009 [cited by applicant]
EP 2144634A1 · 2010 [cited by applicant]
EP 2298407A1 · 2011 [cited by applicant]
EP 2694132A1 · 2014 [cited by applicant]
EP 2562456B1 · 2014 [cited by applicant]
EP 2782633A1 · 2014 [cited by applicant]
EP 1842002B1 · 2015 [cited by applicant]
EP 2736582B1 · 2015 [cited by applicant]
EP 2089094B1 · 2016 [cited by applicant]
EP 2219721B1 · 2017 [cited by applicant]
EP 2753396B1 · 2017 [cited by applicant]
EP 2736584B1 · 2018 [cited by applicant]
EP 3305361A1 · 2018 [cited by applicant]
EP 2271398B1 · 2018 [cited by applicant]
EP 2480281B1 · 2018 [cited by applicant]
EP 2790750B1 · 2018 [cited by applicant]
EP 2331191B1 · 2019 [cited by applicant]
EP 3079756B1 · 2019 [cited by applicant]
EP 2121114B1 · 2019 [cited by applicant]
EP 2719419B1 · 2019 [cited by applicant]
EP 2956204B1 · 2019 [cited by applicant]
EP 3421077B1 · 2019 [cited by applicant]
EP 3530313A1 · 2019 [cited by applicant]
EP 3538201A1 · 2019 [cited by applicant]
EP 3570807A1 · 2019 [cited by applicant]
EP 3570809A1 · 2019 [cited by applicant]
EP 2536463B1 · 2020 [cited by applicant]
EP 3381505B1 · 2020 [cited by applicant]
EP 3538201B1 · 2020 [cited by applicant]
EP 1904152B1 · 2020 [cited by applicant]
EP 2150307B1 · 2020 [cited by applicant]
EP 3313490B1 · 2021 [cited by applicant]
EP 3760275A1 · 2021 [cited by applicant]
EP 3851155A1 · 2021 [cited by applicant]
EP 3517164B1 · 2021 [cited by applicant]
EP 3954355A1 · 2022 [cited by applicant]
EP 3960229A1 · 2022 [cited by applicant]
EP 3973044A1 · 2022 [cited by applicant]
EP 3305361B1 · 2022 [cited by applicant]
EP 3134052B1 · 2022 [cited by applicant]
EP 3530313B1 · 2022 [cited by applicant]
WO WO2021099437A1 · 2021 [cited by applicant]
WO WO2021180675A1 · 2021 [cited by applicant]
WO WO2021252197A1 · 2021 [cited by applicant]
WO WO2022042956A1 · 2022 [cited by applicant]
WO WO2022149339A1 · 2022 [cited by applicant]
WO WO2022207560A1 · 2022 [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2025/039102, dated Nov. 4, 2025, 10 pages. [cited by applicant]
Bangert, Bill, “Shorter times to blood transfusion associated with decreased death risk in trauma patients”, Medical Xpress, Apr. 14, 2016, https://medicalxpress.com/news/2016-04-shorter-blood-transfusion-decreased-deat… [cited by applicant]
ICUMEDICAL, “ChemoClave™ Needlefree Close System Transfer Device (CSTD)”, date unknown, https://www.icumed.com/products/oncology/closed-system-transfer-devices/chemoclave. [cited by applicant]
ICUMEDICAL, “ChemoLock™ Needlefree Closed System Transfer Device (CSTD)”, date unknown, https://www.icumed.com/products/oncology/closed-system-transfer-devices/chemolock. [cited by applicant]
IVTEAM, “Force-activated separation IV connectors”, 2022, Retrieved from the internet https://www.ivteam.com/intravenous-literature/force-activated-separation-iv-connectors/ [Last retrieved Jan. 13, 2023]. [cited by applicant]
Lineus Medical, SafeBreak Product Features and Benefits Brochure, May 2021, mkg 0058 5/21 Rev. 02. [cited by applicant]
PRZen, “Lineus Medical Goes International, Signs ONEY for Distribution in Korea”, PRZen Online Press Release Distribution, PrZen/33448014, MKG-0130 Rev 00, Retrieved from the internet https://przen.com/pr/lineus-medical… [cited by applicant]
Rickard, et al., “Securing All intraVenous devices Effectively in hospitalised patients—the SAVE trial: study protocol for a multicentre randomised controlled trial”, BMJ Open, Sep. 23, 2015;5(9):e008689, doi: 10.1136/b… [cited by applicant]
Tada Group AB, LinkedIn Post “ReLink granted patent in Japan”, LinkedIn, Mar. 2022, retrieved from the internet https://se.linkedin.com/company/tadamedical?trk=public_post_reshare_feed-actor-image&original_referer= [Las… [cited by applicant]
Tribology, “Coefficient of friction, Rolling resistance and Aerodynamics”, date unknown, https://www.tribology-abc.com/abc/cof.htm. [cited by applicant]